Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  genistein
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-12 of 12 for your search:
Start Over
Gemcitabine Hydrochloride and Genistein in Treating Women With Stage IV Breast Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000446089, P30CA022453, WSU-C-2597, NCT00244933
Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 21 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000495776, P30CA022453, WSU-2005-006, WSU-025806MP4F, NCT00376948
Vitamin D and Soy Supplements in Treating Patients With Recurrent Prostate Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CDR0000554969, P30CA012197, CCCWFU-85106, CCCWFU-IRB00000371, NCT00499408
Synthetic Genistein (BONISTEIN™) in Patients Who Are Undergoing Surgery for Prostate Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: P2BV10, NCT00546039
Phase IIb Trial of G-2535 (Unconjugated Isoflavones-100) in Women at High Risk for Breast Cancer
Phase: Phase II
Type: Prevention
Status: Closed
Age: 25 and older
Sponsor: NCI, Other
Protocol IDs: NCI 04B3, NWU03-1-04, NU-NWU03-1-04, NU-NCI-04B3, NU-0835-030, NCT00290758
Genistein in Patients Who Are Undergoing Surgery for Bladder Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000433520, P30CA014520, WCCC-CO-04307, WCCC-UWI03-1-01, WCCC-H-2005-0026, NCT00118040
Genistein in Treating Patients With Prostate Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NCI 09U2, NCI-2010-00941, STU00019487, P50CA090386, NCT01126879
Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2013-00451, UWI09-14-01, CDR0000698228, CO-10805, N01CN35153, P30CA014520, NCT01325311
Phase I Randomized Study of Genistein for Prevention of Cancer in Patients With No History of Cancer or With Asymptomatic Early Prostate Cancer or Other Malignancy
Phase: Phase I
Type: Prevention, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-98-C-0099B
Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal Women
Phase: Phase I
Type: Prevention
Status: Completed
Age: 45 to 70
Sponsor: NCI, Other
Protocol IDs: UNC-GCRC-2107, CDR0000393450, NCT00099008
Effects of GCP on Prostate Cancer.
Phase: No phase specified
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: 200412146, NCT00269555
Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney Cancer
Phase: No phase specified
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NU 04V1, CHIR-NU-04V1, NU-IRB-0310-083, NCT00276835
Start Over